BGU researchers are on the verge of a breakthrough that is bringing the world closer to a cure for diabetes.
Researchers at BGU’s Clinical Islet Laboratory are pursuing three major goals: transplants and new drugs, gene therapy, and the creation of a “transgenic” mouse that can tolerate human material for experimentation. They’re working on new drugs based on the alpha-1-antitrypsin (AAT) protein that reduces inflammation. Recent clinical trials demonstrated that infusion of AAT in recently diagnosed type 1 diabetes patients could eventually eliminate the need for insulin injections. A new clinical trial is under way to evaluate AAT dosing levels and duration.
Diabetes Videossee all videos
Diabetes Newssee all news
New Advice for Type 2 Diabetics: Drink Wine
A BGU study says that those with the disease might experience benefits if they drink wine in moderation.
A Better Way to Predict Diabetes Remission
BGU develops an advanced scoring method to help doctors predict type 2 remission following bariatric surgery.
Wine Tied to Healthier Arteries for Some Diabetics
BGU studied people with type 2 diabetes who drank wine daily as part of a Mediterranean diet.